Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness

Official title: The Effect of Different rTMS Intervention on Acute Experimental Muscular Pain in Individuals Comorbid With Insomnia: a Pilot RCT

Run by The Hong Kong Polytechnic University · NCT07827677 · Data updated 2026-11-12

This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedAugust 31, 2026
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedSeptember 18, 2026
Trial IDNCT07827677 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-60 with insomnia and without chronic musculoskeletal pain, prior lower-limb injuries, or other major exclusion conditions, who are right-handed and eligible for rTMS and pain testing.

Probably not a fit

Individuals with chronic pain, sleep disorders other than insomnia, epilepsy, implanted ferromagnetic devices, or contraindications to vigorous exercise may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, sham-controlled trial, adults with insomnia will receive three sessions of rTMS targeting either the left primary motor cortex or the right dorsolateral prefrontal cortex, plus a sham condition, after a standardized eccentric exercise protocol. The goal is to see if neuromodulation can lessen pain sensitivity and speed recovery from acute musculoskeletal pain associated with insomnia. Participants will be adults aged 18 to 60 who are right-handed and free from chronic pain or major comorbidities. The study uses an established experimental pain model to compare neurostimulation targets. Safety and tolerability of the three interventions will also be monitored.

Why it matters

Potential benefit: If successful, this approach could offer a non-invasive option to reduce pain amplification and promote faster recovery in people whose insomnia worsens musculoskeletal pain.

How similar studies have gone: Previous studies in neuromodulation for pain and sleep-related pain have shown promise, but the specific comparison of L-M1 vs R-DLPFC vs sham in insomnia-related pain is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 60 years
* Right hand and foot dominant

Exclusion Criteria:

* History of any chronic musculoskeletal pain or presence of existing pain during recruitment
* Previous major injuries or surgery involving the lower limbs
* Sleep disorders other than insomnia
* Clinically diagnosed psychiatric disorders
* Conditions that preclude safe rTMS or pain testing (e.g., severe head trauma, intracranial hypertension, implanted ferromagnetic devices, history of epilepsy, skin conditions at stimulation sites)
* Contraindications to vigorous exercise identified through the physical activity readiness questionnaire (PAR-Q)
* Work night shifts or rotating shift schedules
* Pregnant

Where it's running

  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.